Analysis of Genotoxic Nitrosamines in Losartan and Ranitidine Active Pharmaceutical Ingredients
Applications | 2020 | SCIEXInstrumentation
LC/MS, LC/MS/MS, LC/QTRAP
IndustriesPharma & Biopharma
ManufacturerSCIEX
Key wordslosartan, ranitidine, nitrosamine, ndma, genotoxic, avg, nitrosamines, lloq, compounds, 𝑎𝑙𝑙𝑜𝑤𝑒𝑑, 𝑑𝑎𝑖𝑙𝑦, 𝑑𝑜𝑠𝑒, 𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒, 𝑚𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛, 𝑛𝑖𝑡𝑟𝑜𝑠𝑎𝑚𝑖𝑛𝑒, active, 𝐿𝐿𝑂𝑄, 𝑅𝑒𝑞𝑢𝑖𝑟𝑒𝑑, ingredients, easily, respective, acceptable, accura, exposure, validations, sensitivity, prevent, contaminants, pharmaceutical, meet, both, nmba, regulating, neipa, ndipa, workhorse, example, medication, described, translate, revised, ndba, ndea, limits, divert, contaminate, sciex, sold, lower, large
Similar PDF
Highly Selective and Sensitive Method for Quantification of Nitrosamines in Valsartan Drug Substances
2020|SCIEX|Applications
Highly Selective and Sensitive Method for Quantification of Nitrosamines in Valsartan Drug Substances Quantification using SCIEX Triple Quad™ 5500+ LC-MS/MS System − QTRAP® Ready with an ExionLC™ AD System Aman Sharma1, Sandeep Choudhary1, M Chandrasekar1, Manoj Pillai1 SCIEX, India Valsartan…
Key words
valsartan, valsartannitrosamine, nitrosaminesix, sixapi, apiaction, actionnmba, nmbaneipa, neipandipa, ndipandba, ndbandea, ndeandma, ndmalevels, levelsnitrosamines, nitrosaminesnitrosodiisoprpylamine, nitrosodiisoprpylaminenitrosomethylaminobutyric
Rapid Analysis of Genotoxic Nitrosamines by HPLC-MS/MS
2019|SCIEX|Applications
Rapid Analysis of Genotoxic Nitrosamines by HPLC-MS/MS Sensitive, Robust Assay Using a SCIEX Triple Quad™ 4500 System and the ExionLC™ System Lihai Guo, Zhimin Long, Xiangyang Leng APAC Applications Support Center, China Introduction Genotoxic impurities (GTI’s) are intermediate, reactive products…
Key words
ndela, ndelanmor, nmornpyr, npyrnpip, npipndpa, ndpandba, ndbandea, ndeandma, ndmaexionlc, exionlcrecovery, recoverynitrosodi, nitrosodigenotoxic, genotoxicnitrosamines, nitrosaminesquantitaiton, quantitaiton𝜇𝑔
N-Nitrosodimethylamine (NDMA) Analysis in Ranitidine Active Pharmaceutical Ingredient and Drug Product Using QTRAP® 4500 System
2019|SCIEX|Others
Quantify NDMA using the SCIEX QTRAP® 4500 LC-MS/MS System N-Nitrosodimethylamine (NDMA) Analysis in Ranitidine Active Pharmaceutical Ingredient and Drug Product Using QTRAP® 4500 System The presence of nitrosamines, especially NDMA, has been identified in ranitidine drug products by the United…
Key words
ndma, ndmaranitidine, ranitidinespiked, spikedprove, provenitrosodimethylamine, nitrosodimethylaminelloq, lloqspec, specconcentration, concentrationregulatory, regulatorylod, lodquantify, quantifystandard, standarduseful, usefulppm, ppmmuch
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|GuidesPresentations
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Key words
back, backndma, ndmaneipa, neipafda, fdandipa, ndipandea, ndeandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apivalsartan, valsartanbest, bestquant, quantdichloromethan